Losacard 25 Tablet contains Losartan 25 mg, an angiotensin II receptor antagonist primarily used to manage hypertension and reduce the risk of stroke in patients with left ventricular hypertrophy. Losartan works by selectively blocking the binding of angiotensin II to the AT1 receptor, thereby inhibiting vasoconstriction and aldosterone secretion, which leads to vasodilation and decreased blood pressure. This mechanism helps in lowering systemic vascular resistance and improving cardiac output. Losacard 25 is indicated for the treatment of essential hypertension, diabetic nephropathy in patients with type 2 diabetes and hypertension, and for the prevention of stroke in hypertensive patients with left ventricular hypertrophy. The medication is generally well tolerated, with common adverse effects including dizziness, upper respiratory infections, and fatigue. It is contraindicated in patients with hypersensitivity to Losartan or any component of the formulation, and caution is advised in patients with renal or hepatic impairment. Losacard 25 should not be used during pregnancy due to the risk of fetal toxicity. Dosage adjustments may be necessary based on clinical response and patient condition. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy to ensure safety and efficacy.